Trial Outcomes & Findings for Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity (NCT NCT00608465)
NCT ID: NCT00608465
Last Updated: 2017-08-11
Results Overview
Recruitment status
TERMINATED
Study phase
PHASE4
Target enrollment
4 participants
Primary outcome timeframe
10-Week period
Results posted on
2017-08-11
Participant Flow
Participant milestones
| Measure |
All Patients
The study was never unblinded as enrollment was never completed.
|
|---|---|
|
Overall Study
STARTED
|
4
|
|
Overall Study
COMPLETED
|
4
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
Baseline characteristics by cohort
| Measure |
All Patients
n=4 Participants
The study was never unblinded as enrollment was never completed.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=93 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
4 Participants
n=93 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=93 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=93 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=93 Participants
|
|
Region of Enrollment
United States
|
4 participants
n=93 Participants
|
PRIMARY outcome
Timeframe: 10-Week periodPopulation: Enrollment was never completed so study was never unblinded and data was never analyzed
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: 10-weeksPopulation: Enrollment was never completed so study was never unblinded and data was never analyzed
Outcome measures
Outcome data not reported
Adverse Events
All Patients
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place